Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:49 PM
Ignite Modification Date:
2025-12-24 @ 4:49 PM
NCT ID:
NCT05563350
Eligibility Criteria:
Inclusion Criteria:
* Age ≥18 years
* Treatment with minimum 200 mg chlordiazepoxide for alcohol withdrawal symptoms during hospital admission
* Acute admittance to ICU or HDU due to respiratory insufficiency, impaired consciousness or agitation.
* Inclusion possible within 12 h of ICU/HDU admission.
Exclusion Criteria:
* Allergies to omeprazole/esomeprazole and midazolam
* Treatment with chlordiazepoxide within the first 12 h after inclusion (from blood samples at inclusion until blood samples 12 h after inclusion)
* Treatment with omeprazole/esomeprazole within 1 day prior to ICU/HDU admission and within the first 12 h after inclusion.
* Treatment with midazolam within 1 day prior to ICU/HDU admission
* Cardiac arrest prior to admission
* Pregnancy (a negative hcg (from urine or blood sample) has to be present before inclusion of women aged \<50 years)
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT05563350
Study Brief:
Protocol Section:
NCT05563350